Senate Bill sb0636
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    By Senator Burt
    16-516A-02
  1                      A bill to be entitled
  2         An act relating to controlled substances;
  3         providing for specified licensing boards to
  4         adopt rules governing the prescribing of
  5         controlled substances; requiring certain health
  6         care providers to complete education courses
  7         relating to the prescription of controlled
  8         substances; providing penalties and requiring a
  9         report; providing for the emergency suspension
10         of certain licenses for prescribing violations;
11         requiring the Department of Health and the
12         Department of Law Enforcement to share certain
13         information regarding health care
14         practitioners; requiring a report; requiring
15         the Department of Legal Affairs to establish an
16         electronic system to monitor the prescribing of
17         certain controlled substances; establishing an
18         advisory council and providing for its
19         membership, duties, staff, and compensation;
20         amending s. 456.033, F.S.; eliminating certain
21         requirements for HIV and AIDS education
22         courses; amending s. 456.072, F.S.; requiring a
23         fine for certain violations involving excessive
24         prescribing of controlled substances; amending
25         s. 458.345, F.S.; requiring certain resident
26         physicians, interns, and fellows to complete an
27         educational course in prescribing controlled
28         substances; amending s. 461.013, F.S.;
29         prohibiting the presigning of blank
30         prescription forms and providing penalties;
31         amending s. 893.04, F.S.; providing additional
                                  1
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         requirements for pharmacists regarding the
  2         identification of persons to whom controlled
  3         substances are dispensed; prohibiting certain
  4         prescribing practitioners from possessing,
  5         administering, dispensing, or prescribing
  6         controlled substances; creating s. 893.065,
  7         F.S.; establishing protocols requiring
  8         prescriptions for certain controlled substances
  9         to be issued on special forms developed by the
10         Department of Legal Affairs; establishing
11         requirements for the design, issuance, and
12         control of such forms; providing record-keeping
13         requirements; providing other requirements for
14         the use of such forms; creating s. 893.0655,
15         F.S.; requiring certain practitioners to
16         surrender such prescription forms; providing an
17         effective date.
18
19  Be It Enacted by the Legislature of the State of Florida:
20
21         Section 1.  Physicians; rules establishing prescribing
22  guidelines.--To minimize the diversion and resultant abuse of
23  controlled substances, the Board of Medicine and the Board of
24  Osteopathic Medicine shall adopt rules to establish guidelines
25  for prescribing controlled substances to patients in emergency
26  department settings. Such guidelines must allow physicians to
27  provide legitimate medical treatment of acute and chronic pain
28  and require them to recognize and prevent abuse of pain
29  medications prescribed in emergency department settings. Each
30  board shall consult with the Florida College of Emergency
31  Physicians in developing these guidelines.
                                  2
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         Section 2.  Instruction required for certain licensees
  2  in prescribing and pharmacology.--
  3         (1)  The appropriate professional licensing board shall
  4  require each person licensed under chapter 458, chapter 459,
  5  chapter 461, chapter 462, or chapter 466, Florida Statutes, to
  6  complete a continuing educational course, approved by the
  7  board, on appropriate prescribing and pharmacology of
  8  controlled substances, as part of the licensee's initial
  9  license renewal after January 1, 2003. The course shall
10  provide education in the state and federal laws and rules
11  governing the prescribing and dispensing of controlled
12  substances; in appropriate evaluation of patients for any risk
13  of drug diversion and the resulting abuse of controlled
14  substances; in the use of informed consent and other
15  protocols, such as discussing the risks and benefits of using
16  controlled substances, with patients to prevent drug
17  diversion; in the need to keep accurate and complete medical
18  records to justify treatment with controlled substances; in
19  addiction and substance-abuse issues with respect to patients;
20  in the appropriate use of recognized pain-management
21  guidelines; and in the need for consultation and referral of
22  patients who are at risk for misuse of medication or diversion
23  of controlled substances, when appropriate.
24         (2)  Such licensees must submit confirmation of
25  completion of such a course, on a form provided by the board,
26  when submitting fees for the initial biennial license renewal
27  after January 1, 2003.
28         (3)  The board may approve additional equivalent
29  courses that satisfy the requirements of subsection (1). Each
30  licensing board that requires a licensee to complete an
31  educational course pursuant to this section may include the
                                  3
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  hours required to complete the course in the total required
  2  continuing educational requirements.
  3         (4)  Any person who holds two or more licenses subject
  4  to this section may satisfy the requirements of this section
  5  by taking only one such board-approved course for relicensure
  6  of all such licenses.
  7         (5)  A licensee who fails to comply with this section
  8  is subject to disciplinary action under each respective
  9  practice act and section 456.072(1)(k), Florida Statutes. In
10  addition to discipline by the board, the licensee must
11  complete the course.
12         (6)  The board shall require, as a condition of
13  granting a license under the chapter specified in subsection
14  (1), that an applicant for initial licensure complete an
15  educational course in the appropriate prescribing and
16  pharmacology of controlled substances. An applicant who has
17  not taken a course at the time of licensure shall, upon
18  submitting an affidavit showing good cause, be allowed 6
19  months within which to complete this requirement.
20         (7)  The board may adopt rules necessary to administer
21  this section.
22         (8)  Each board shall report to the President of the
23  Senate, the Speaker of the House of Representatives, and the
24  chairpersons of the appropriate substantive committees of the
25  Legislature by March 1 of each year on the implementation of
26  and compliance with this section.
27         Section 3.  Emergency suspension orders; controlled
28  substances.--Upon receipt of sufficient evidence from any
29  agency authorized to enforce chapter 893, Florida Statutes,
30  regarding a violation of sections 458.331(1)(q),
31  458.331(1)(r), 458.331(1)(aa), 459.015(1)(t), 459.015(1)(u),
                                  4
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  459.015(1)(ee), 461.013(1)(o), 461.013(1)(p), 461.013(1)(dd),
  2  462.14(1)(q), 462.14(1)(r), 462.14(1)(aa), 464.018(1)(i),
  3  465.016(1)(e), 465.016(1)(i), 466.028(1)(p), 466.028(1)(q),
  4  466.028(1)(r), or 466.028(1)(dd) or of chapter 893, Florida
  5  Statutes, by a licensed health care practitioner who is
  6  authorized to prescribe, dispense, or administer controlled
  7  substances, the Department of Health shall recommend the
  8  suspension or restriction of the practitioner's license to the
  9  Secretary of Health within 10 working days after receiving
10  such evidence. The Secretary of Health may suspend or restrict
11  the license of the practitioner in accordance with section
12  120.60(6), Florida Statutes.
13         Section 4.  Sharing of arrest and other information
14  regarding certain health care practitioners.--
15         (1)  The Department of Health shall electronically
16  submit to the Department of Law Enforcement a list of health
17  care practitioners licensed in this state who are authorized
18  to prescribe, dispense, or administer controlled substances.
19  In order to facilitate the efficiency of the Department of
20  Health's investigation of applicable violations involving the
21  diversion of controlled substances by such practitioners, the
22  Department of Law Enforcement shall, when practicable, notify
23  and provide investigative information to the Department of
24  Health regarding the arrest of any such practitioner.
25         (2)  The Medical Examiner's Commission within the
26  Department of Law Enforcement shall report quarterly to the
27  Department of Health any deaths attributed to the abuse of
28  controlled substances, based on autopsy reports completed
29  within this state, and any other public information that may
30  facilitate that department's expeditious investigation of the
31  information to determine whether any of the deaths have
                                  5
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  involved conduct by a licensed health care practitioner which
  2  is subject to disciplinary action under section 456.073,
  3  Florida Statutes. The Department of Health or the board having
  4  regulatory authority over the practitioner shall investigate
  5  any information received by the department or the board when
  6  it has reasonable grounds to believe that the practitioner has
  7  violated any law relating to the practitioner's practice.
  8         (3)  To help the Department of Health and regulatory
  9  boards control the diversion and resultant abuse of controlled
10  substances, the Department of Health and the Department of Law
11  Enforcement shall study the feasibility of expanding the
12  electronic exchange of information to facilitate the transfer
13  to the Department of Health of criminal history information
14  involving licensed health care practitioners who are
15  authorized to prescribe, administer, or dispense controlled
16  substances. The Department of Law Enforcement shall
17  investigate the feasibility of the electronic transmission of
18  information from medical examiners within this state to the
19  Department of Health regarding autopsies and other public
20  reports that attribute death to controlled-substance abuse.
21  The Department of Law Enforcement, in consultation with the
22  Department of Health, must submit a report of its findings to
23  the Legislature by November 1, 2002.
24         Section 5.  Electronic monitoring system for
25  prescriptions.--
26         (1)  By July 1, 2003, the Department of Legal Affairs
27  shall design and establish an electronic system to monitor the
28  prescribing of Schedule II and Schedule III controlled
29  substances by health care practitioners within the state or
30  the dispensing of such controlled substances to an address
31
                                  6
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  within the state by a pharmacy permitted or registered by the
  2  Board of Pharmacy.
  3         (2)  The Attorney General may, by rule, designate any
  4  opiate listed as a Schedule IV controlled substance for
  5  inclusion in such system.
  6         (3)  Each pharmacist or other person authorized by law
  7  to dispense controlled substances within this state must
  8  timely report to the Department of Legal Affairs the data
  9  required by this section each time that:
10         (a)  A Schedule II controlled substance is dispensed;
11         (b)  A Schedule III controlled substance is dispensed;
12  or
13         (c)  An opiate is dispensed which is listed in Schedule
14  IV as a controlled substance and is designated by the Attorney
15  General.
16         (4)  The data required under this section includes:
17         (a)  The patient's name.
18         (b)  The patient's address.
19         (c)  The national drug code number of the substance
20  dispensed.
21         (d)  The date that the substance is dispensed.
22         (e)  The quantity of substance dispensed.
23         (f)  The dispenser's United States Drug Enforcement
24  Administration Number.
25         (g)  The prescribing practitioner's United States Drug
26  Enforcement Administration Number.
27         (5)  The information must be reported within 15 days
28  after the date the controlled substance is dispensed.
29         (6)  A dispenser must transmit the information required
30  by this section in an electronic format specified by the
31
                                  7
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  Department of Legal Affairs unless a specific waiver is
  2  granted by the department to that dispenser.
  3         (7)  The Department of Legal Affairs shall establish a
  4  7-member prescription monitoring program advisory council to
  5  assist it in implementing the system.
  6         (a)  The Governor shall appoint members to serve on the
  7  advisory council. The members of the council shall include the
  8  Attorney General or his or her designee, the Secretary of
  9  Health or his or her designee, the executive director of the
10  Department of Law Enforcement or his or her designee, the
11  director of the Office of Drug Control within the Executive
12  Office of Governor or his or her designee, a health care
13  practitioner who is licensed in this state and authorized to
14  prescribe controlled substances, a pharmacist who is licensed
15  in this state, and a prosecutor who has expertise in the
16  criminal prosecution of drug-diversion cases.
17         (b)  The advisory council members shall serve without
18  compensation but may receive reimbursement, as provided in
19  section 112.061, Florida Statutes, for per diem and travel
20  expensed incurred in the performance of their official duties.
21         (c)  The Department of Legal Affairs shall provide
22  staff and other administrative assistance that is reasonably
23  necessary to assist the advisory council in carrying out its
24  responsibilities. The advisory council is abolished July 1,
25  2003.
26         (8)  The Department of Legal Affairs shall adopt rules
27  pursuant to section 120.536(1) and section 120.574, Florida
28  Statutes, necessary to administer this section.
29         Section 6.  Subsections (1) and (9) of section 456.033,
30  Florida Statutes, are amended to read:
31
                                  8
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         456.033  Requirement for instruction for certain
  2  licensees on HIV and AIDS.--
  3         (1)  The appropriate board shall require each person
  4  licensed or certified under chapter 457; chapter 458; chapter
  5  459; chapter 460; chapter 461; chapter 463; part I of chapter
  6  464; chapter 465; chapter 466; part II, part III, part V, or
  7  part X of chapter 468; or chapter 486 to complete a continuing
  8  educational course, approved by the board, on human
  9  immunodeficiency virus and acquired immune deficiency syndrome
10  as part of biennial relicensure or recertification. The course
11  shall consist of education on the modes of transmission,
12  infection control procedures, clinical management, and
13  prevention of human immunodeficiency virus and acquired immune
14  deficiency syndrome. Such course shall include information on
15  current Florida law on acquired immune deficiency syndrome and
16  its impact on testing, confidentiality of test results,
17  treatment of patients, and any protocols and procedures
18  applicable to human immunodeficiency virus counseling and
19  testing, reporting, the offering of HIV testing to pregnant
20  women, and partner notification issues pursuant to ss. 381.004
21  and 384.25.
22         (9)(a)  In lieu of completing a course as required in
23  subsection (1), the licensee may complete a course in
24  end-of-life care and palliative health care, so long as the
25  licensee completed an approved AIDS/HIV course in the
26  immediately preceding biennium.
27         (b)  In lieu of completing a course as required by
28  subsection (1), a person licensed under chapter 466 who has
29  completed an approved AIDS/HIV course in the immediately
30  preceding 2 years may complete a course approved by the Board
31  of Dentistry.
                                  9
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         Section 7.  Paragraph (d) of subsection (2) of section
  2  456.072, Florida Statutes, is amended to read:
  3         456.072  Grounds for discipline; penalties;
  4  enforcement.--
  5         (2)  When the board, or the department when there is no
  6  board, finds any person guilty of the grounds set forth in
  7  subsection (1) or of any grounds set forth in the applicable
  8  practice act, including conduct constituting a substantial
  9  violation of subsection (1) or a violation of the applicable
10  practice act which occurred prior to obtaining a license, it
11  may enter an order imposing one or more of the following
12  penalties:
13         (d)  Imposition of an administrative fine not to exceed
14  $25,000 $10,000 for each count or separate offense. If the
15  violation is for fraud or making a false or fraudulent
16  representation, the board, or the department if there is no
17  board, must impose a fine of $10,000 per count or offense. If
18  the violation is for inappropriate or excessive prescribing of
19  any controlled substance, the board, or the department if
20  there is no board, must impose a fine of $25,000 per count or
21  offense.
22         Section 8.  Paragraph (d) is added to subsection (1) of
23  section 458.345, Florida Statutes, to read:
24         458.345  Registration of resident physicians, interns,
25  and fellows; list of hospital employees; prescribing of
26  medicinal drugs; penalty.--
27         (1)  Any person desiring to practice as a resident
28  physician, assistant resident physician, house physician,
29  intern, or fellow in fellowship training which leads to
30  subspecialty board certification in this state, or any person
31  desiring to practice as a resident physician, assistant
                                  10
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  resident physician, house physician, intern, or fellow in
  2  fellowship training in a teaching hospital in this state as
  3  defined in s. 408.07(44) or s. 395.805(2), who does not hold a
  4  valid, active license issued under this chapter shall apply to
  5  the department to be registered and shall remit a fee not to
  6  exceed $300 as set by the board.  The department shall
  7  register any applicant the board certifies has met the
  8  following requirements:
  9         (d)  Has completed, upon initial registration, a 2-hour
10  educational course in the prescribing of controlled
11  substances. The course shall consist of education in state and
12  federal laws and rules governing the prescribing and
13  dispensing of controlled substances; in appropriate evaluation
14  of patients for any risk of drug diversion and the resulting
15  abuse of controlled substances; in the use of informed consent
16  and other protocols, such as a discussion of the risks and
17  benefits of the use of controlled substances with patients to
18  prevent drug diversion; in the need to keep accurate and
19  complete medical records to justify treatment with controlled
20  substances; in addiction and substance-abuse issues with
21  respect to patients; in the appropriate use of recognized
22  pain-management guidelines; and in the need for consultation
23  and referral of patients who are at risk for misuse of their
24  medication or diversion of controlled substances, when
25  appropriate. An applicant who has not taken a course at the
26  time of registration shall, upon submitting an affidavit
27  showing good cause, be allowed 6 months within which to
28  complete this requirement.
29         Section 9.  Paragraph (dd) is added to subsection (1)
30  of section 461.013, Florida Statutes, to read:
31
                                  11
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         461.013  Grounds for disciplinary action; action by the
  2  board; investigations by department.--
  3         (1)  The following acts constitute grounds for denial
  4  of a license or disciplinary action, as specified in s.
  5  456.072(2):
  6         (dd)  Presigning blank prescription forms.
  7         Section 10.  Paragraph (h) is added to subsection (1)
  8  of section 893.04, Florida Statutes, and subsection (4) is
  9  added to that section, to read:
10         893.04  Pharmacist and practitioner.--
11         (1)  A pharmacist, in good faith and in the course of
12  professional practice only, may dispense controlled substances
13  upon a written or oral prescription of a practitioner, under
14  the following conditions:
15         (h)  A pharmacist may not dispense a controlled
16  substance to any individual not known to the pharmacist,
17  without first obtaining proper identification and documenting,
18  by signature on a log book kept by the pharmacist, the
19  identity of the individual obtaining the controlled substance.
20  If the individual does not have proper identification, the
21  pharmacist must verify the validity of the prescription and
22  identity of the patient with the prescribing practitioner, or
23  the prescribing practitioner's authorized agent, before
24  dispensing the controlled substance. For purposes of this
25  section, identification is proper only if it contains the
26  photograph, the printed name, and the signature of the
27  individual obtaining the controlled substance.
28         (4)  Any prescribing practitioner who surrenders, by
29  court order, or order of any state or governmental agency, or
30  voluntarily, his or her controlled substance privileges may
31  not possess, administer, dispense, or prescribe a controlled
                                  12
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  substance unless those privileges have been restored and the
  2  practitioner has obtained current registration from the
  3  appropriate federal agency as provided by law.
  4         Section 11.  Section 893.065, Florida Statutes, is
  5  created to read:
  6         893.065  Triplicate prescriptions required for certain
  7  controlled substances.--
  8         (1)  On or after July 1, 2002, a person may not issue a
  9  prescription for a Schedule II or Schedule III controlled
10  substance, or an opiate listed in Schedule IV which has been
11  designed by the Attorney General by rule, unless the
12  prescription meets the requirements of this section.
13         (2)  The Department of Legal Affairs shall develop a
14  counterfeit-proof prescription blank for use by practitioners
15  who prescribe controlled substances classified in:
16         (a)  Schedule II;
17         (b)  Schedule III; or
18         (c)  Schedule IV, as an opiate that is designated by
19  the Attorney General by rule.
20         (3)  Prescription blanks shall be issued by the
21  Department of Legal Affairs to such practitioners in serially
22  numbered groups of not more than 100 forms each in triplicate,
23  unless a practitioner orally, electronically, or in writing
24  requests a larger quantity. The prescription blanks must be
25  printed on distinctive paper; must contain the serial number
26  of the group; must be sequentially numbered; and must bear the
27  preprinted full name, address, and category of professional
28  licensure of the practitioner to whom they are issued and that
29  practitioner's federal registry number for controlled
30  substances. The prescription blanks may not be transferred.
31
                                  13
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         (4)  The Department of Legal Affairs may charge a fee
  2  for the prescription blanks in an amount sufficient to
  3  reimburse the department for its actual costs of preparing,
  4  issuing, and tracking such forms.
  5         (5)  Notwithstanding s. 893.04(1)(a)-(d), a person may
  6  not prescribe a Schedule II or Schedule III controlled
  7  substance, or an opiate listed in Schedule IV which has been
  8  designated by the Attorney General by rule, nor may any person
  9  fill, compound, or dispense such a prescription, unless it
10  complies with this section.
11         (a)  The signature on each such prescription form must
12  be wholly written in ink or indelible pencil in the
13  handwriting of the prescribing practitioner. Each prescription
14  must be prepared in triplicate, dated, and signed by the
15  prescribing practitioner on the day when issued, and must
16  contain, typewritten or handwritten by the physician or an
17  employee of the physician, the full name and address of the
18  person for whom, or the owner of the animal for which, the
19  controlled substance is prescribed; the name, quantity, and
20  strength of the controlled substance; directions for use; and
21  the address, category of professional licensure, and federal
22  controlled substance registration number of the prescribing
23  practitioner. If the prescription is for an animal, the
24  prescription must state the species of animal for which it is
25  prescribed. If the prescribing practitioner does not specify
26  the address of the person for whom, or animal for which, the
27  prescription is prescribed, the pharmacist filling the
28  prescription or an employee acting under the direction of the
29  pharmacist must write or type the address on the prescription
30  or maintain the information in a readily retrievable form in
31  the pharmacy.
                                  14
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1         (b)  The original and duplicate of the prescription
  2  must be delivered to the pharmacist filling the prescription.
  3  The duplicate must be retained on file by the proprietor of
  4  the pharmacy in which it is filled for a period of 2 years,
  5  and the original, properly endorsed by the pharmacist with the
  6  name and address of the pharmacy, the pharmacy's state permit
  7  number, the date that the prescription was filled, and the
  8  signature of the pharmacist, must be transmitted to the
  9  Department of Legal Affairs at the end of the month in which
10  the prescription was filled. Notwithstanding any provision of
11  this section, the prescribing practitioner's address, category
12  of professional licensure, or federal controlled substances
13  registration number need not appear on the prescription if
14  that information is readily retrievable in the pharmacy.
15         (c)  All prescriptions issued for a Schedule II or
16  Schedule III controlled substance, or an opiate listed in
17  Schedule IV which has been designated by the Attorney General
18  by rule, must include both a written and numerical notation of
19  quantity on the face of the prescription.
20         (d)  A pharmacist may not dispense more than a 30-day
21  supply of a controlled substance listed in Schedule III upon
22  an oral prescription.
23         (e)  A pharmacist may not knowingly fill a prescription
24  that has been mutilated or forged for a Schedule II or
25  Schedule III controlled substance, or an opiate listed as a
26  Schedule IV controlled substance which has been designated by
27  the Attorney General by rule.
28         (f)  Any controlled substance listed in Schedule III,
29  or any controlled substance that is an opiate listed as a
30  controlled substance in Schedule IV and which has been
31  designated by the Attorney General by rule, may be dispensed
                                  15
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  by a pharmacist upon an oral prescription, if before filling
  2  the prescription, the pharmacist reduces it to writing in ink
  3  or indelible pencil in the handwriting of the pharmacist, upon
  4  an official form issued by the Department of Legal Affairs for
  5  that purpose. Such prescriptions must be prepared in
  6  triplicate and must contain the date of the oral authorization
  7  and the information required by paragraph (a).
  8         Section 12.  Section 893.0655, Florida Statutes, is
  9  created to read:
10         893.0655  Surrender of prescription blanks.--
11         (1)  When a practitioner who is named in a warrant of
12  arrest for, or is charged in an accusatory pleading with, a
13  felony violation of chapter 499 or chapter 893, the court in
14  which the pleading is filed or the magistrate who issued the
15  warrant shall, upon the motion of a law enforcement agency,
16  supported by probable cause, issue an order requiring the
17  practitioner to surrender to the clerk of the court all
18  triplicate prescription blanks in the practitioner's
19  possession at a specified time and shall direct the Department
20  of Health to withhold prescription blanks from the
21  practitioner. The law enforcement agency obtaining the order
22  shall notify the Department of Health of this order. Except as
23  provided in subsection (2), the order shall remain in effect
24  until further order of the court. Any practitioner possessing
25  prescription blanks in violation of the order commits a
26  misdemeanor of the first degree, punishable as provided in s.
27  775.082, s. 775.083, or s. 775.084.
28         (2)  Such order shall be vacated if the court or
29  magistrate finds that the underlying violation is not
30  supported by reasonable cause, at a hearing held within two
31  court days after the practitioner files and personally serves
                                  16
CODING: Words stricken are deletions; words underlined are additions.
    Florida Senate - 2002                                   SB 636
    16-516A-02
  1  upon the prosecuting attorney and the law enforcement agency
  2  that obtained the order a notice of motion to vacate the
  3  order, with any affidavits on which the practitioner relies.
  4  At the hearing, the burden of proof, by a preponderance of the
  5  evidence, is on the prosecution. Evidence presented at the
  6  hearing shall be limited to the warrant of arrest with
  7  supporting affidavits, the motion to require the defendant to
  8  surrender all triplicate prescription blanks with supporting
  9  affidavits, the sworn complaint and any documents or reports
10  incorporated by reference thereto, which, if based on
11  information and belief, state the basis for the information,
12  or any other documents of similar reliability, as well as
13  affidavits submitted by the prosecution and defense. Granting
14  of the motion to vacate the order is no bar to prosecution of
15  the alleged violation.
16         Section 13.  This act shall take effect July 1, 2002.
17
18            *****************************************
19                          SENATE SUMMARY
20    Provides for the regulation of the prescribing of
      controlled substances. Requires education and continuing
21    education in the prescribing of controlled substances by
      specified practitioners. Establishes penalties. Requires
22    certain state agencies to share information. Requires the
      creation of an electronic monitoring system. Creates an
23    advisory council. Prohibits presigning prescriptions.
      Requires state issuance and regulation of prescription
24    forms for controlled substances. Prohibits certain
      practitioners from prescribing. Establishes
25    record-keeping requirements. Requires certain
      practitioners to surrender their prescription forms. (See
26    bill for details.)
27
28
29
30
31
                                  17
CODING: Words stricken are deletions; words underlined are additions.